Apyx shareholder alert: jakubowitz law reminds apyx shareholders of a lead plaintiff deadline of august 5, 2022

New york , july 1, 2022 /prnewswire/ -- jakubowitz law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of apyx medical corporation (nasdaq: apyx). to receive updates on the lawsuit, fill out the form: https://claimyourloss.com/securities/apyx-medical-corporation-loss-submission-form/?id=29418&from=4 the lawsuit seeks to recover losses for shareholders who purchased apyx between may 12, 2021 and march 11, 2022.
APYX Ratings Summary
Quant
APYX Quant Ranking
Sector
Industry
Quant Rating
Quant Score